PRKN and Parkinson disease: Pathogenic mutations in the PRKN gene lead to dysregulation of mitochondrial turnover in neurons (49) as well as defects in synaptic endocytosis, the inadequate function of which was suggested to lead to dopamine accumulation and subsequent toxicity to dopaminergic neurons, which is a hallmark of Parkinson’s Disease (50).